Corbus Pharmaceuticals Holdings Inc


Market Cap$467.44M

Compare Corbus Pharmaceuticals Holdings

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Corbus Pharmaceuticals Holdings IncCorbus Pharmaceuticals Holdings Inc-10.20%-66%-0.3
marketMarket Avg54.31.27%32%-1.3
HealthcareHealthcare Avg39.11.36%17%7.21.3

Target Price by Analysts

0.2% upsideCorbus Pharmaceuticals Holdings Target Price DetailsTarget Price

Current Fair Value

103.5% downside

Overvalued by 103.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$467.44 Million
Enterprise Value$389.29 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.37
Outstanding Shares10,686,693
Avg 30 Day Volume262,058


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-10.24
Price to Sales-
Price to Book Ratio7.65
Enterprise Value to Revenue441.52
Enterprise Value to EBIT-6.95
Enterprise Value to Net Income-9
Total Debt to Enterprise0.05
Debt to Equity0.28

Revenue Sources

No data

ESG Score

No data

About Corbus Pharmaceuticals Holdings Inc

CEO: Yuval Cohen